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Introduction
It is estimated that, worldwide, over one billion people smoke tobacco. The detrimental consequences of smoking on health are well known and include coronary heart disease, lung cancer and chronic obstructive pulmonary disease. The heritability of nicotine dependence has long been established and we know that approximately 40-60% of nicotine dependence is due to genetic contributions, while the remainder is largely environmental [1] [2] [3] . In the past few years, genome-wide linkage and association studies have identified several candidate genes (e.g., GABAB2, CHRNA4, DDC, BDNF, and COMT.) [4] [5] [6] . Saccone et al. identified and screened 449 human genes putatively involved with nicotine dependence [6] . In addition to identifying the genes, it is important to understand their functions and interactions, including their involvement in biological pathways. For example, from a research management perspective, identification of "hub" genes (i.e., genes involved in multiple pathways) can help identify further research efforts.
Complex biological queries generally require the integration of information from several sources. For example, gene information sources, such as Entrez Gene [7] , might need to be integrated with pathway information sources, such as KEGG (Kyoto Encyclopedia for Genes and Genomics) [8] . Moreover, comparing results across model organisms requires homology information (provided for example by HomoloGene [9] ). These resources, described in detail later in section 4.4, are generally cross-referenced, which makes it possible for users to navigate among them in web-based environments. Interlinking is not the same as integration, however; and these resources do not support the automatic and high-throughput information processing required for answering complex queries over large amounts of data from heterogeneous sources. An effective integration strategy is also critical to support the e-Science paradigm that is characterized by the large volumes of data generated by industrial-scale in-silico processes [10] .
The first obstacle to integration is the format used for the representation of these information sources. The resources available from the National Center for Biotechnology Information (NCBI) Entrez system, such d r a f t 4 as Entrez Gene and HomoloGene, are available in multiple formats, including XML. Although XML standardizes the representation of information from a syntactic perspective, it does not make explicit the relations among the various types of entities in a given resource or across resources. In other words, although the XML file for Entrez Gene is machine-processable, it cannot be integrated easily or automatically with other information sources without human intervention. In contrast, the pathway research community has created a common, formal knowledge model called BioPAX [11] to represent biological pathway data. BioPAX also provides an information model for representing those data with formally defined semantics, which includes explicitly modeling the relationships between different pathway entities.
Recent research in Semantic Web technologies has delivered promising results for information integration across heterogeneous knowledge sources [12] [13] [14] [15] . In effect, the Semantic Web provides a robust framework that enables the integration, sharing, and reuse of data from multiple sources. Additionally, the use of a representation based on a formal language allows software applications to reason over information. Commonly used Semantic Web technologies include ontology modeling languages such as Web Ontology Language (OWL) [16] , data models such as the Resource Description Framework (RDF)
[17], the SPARQL query language [18] , and OWL reasoners such as Pellet [19] and Racer [20] .
Reasoning tools have been successfully applied over knowledge bases to address biological and health care problems [13, [21] [22] [23] [24] [25] .
The objective of this paper is to illustrate how Semantic Web technologies can support information integration and facilitate the creation of semantically integrated resources, called semantic mashups, for gene and pathway information. We show how complex biological queries can be answered by the mashups. More precisely, in the context of understanding the genetic basis of nicotine dependence, we integrate gene and pathway information in order to answer the following queries: Which genes participate in a large number of pathways? Which genes (or gene products) interact with each other? Which genes are expressed in the brain?
The rest of the paper is organized as follows. In section 2, we justify the use of ontology-based integration and summarize relevant work on the use of Semantic Web technologies in biomedicine. In section 3, we present the ontological framework we created to support the integration. The information sources integrated are presented in section 4, along with our integration strategy. Three biological queries and the corresponding answers extracted from our knowledge base are explored in section 5. In section 6, we discuss the significance of this study, as well as its limitations. Our conclusions are presented in section 7.
Supplementary materials, including the set of SPARQL queries used in this study and the EKoM schema, are available at http://knoesis.wright.edu/research/lifesci/integration/structured_data/JBI-2008/.
Background
In this section, we discuss the rationale for ontology-based integration and summarize relevant work on the use of Semantic Web technologies in biomedicine.
Ontology-based data integration
The traditional approach to integrating gene and pathway information is to create a relational data model that can be used to integrate and store both kinds of data. As the experience of the biological pathway research community with the BioPAX ontology clearly shows, there are many advantages to using an ontology as a knowledge representation model for integrating data from heterogeneous sources [11, 22] .
One advantage is that the formal semantics of an ontology enable software applications to interpret ontology instance data consistently and reason over them. For example, the entities 'gene' and 'molecular function' are represented in the ontology, where they are linked by the relationship 'has_function. ' 1 At the instance level, a particular gene (e.g., Chrna4 in mouse) has a particular function (e.g., 'nicotinic acetylcholine-activated cation-selective channel activity'). This advantage has been discussed in a wide 1 In this paper, we represent ontology concepts in italics and within single quotes (e.g. 'pathway') d r a f t 6 range of application domains including national security [26] , geographical information systems [27] and biomedical informatics [28] .
Complex biological queries require precisely this kind of reasoning over a large number of instances.
Although scientists can easily interpret the connections among entities, they generally are unable to process large amounts of data consistently. Conversely, computers can identify connections in large graphs, but require that relations be explicitly represented. To identify common pathways among homologous genes from the 449 genes putatively involved with nicotine dependence, for example, two types of (instance-level) information need to be extracted from the relevant knowledge bases and processed: homology information and gene-pathway relations. The corresponding types of entities (here, 'gene' and 'pathway') and relations ('homologous_with' and 'involved_in') must be represented in the corresponding information model or ontology.
From a theoretical perspective, without a knowledge model associated with the RDF instance data, the discovery of new knowledge through entailment reasoning will be limited. (Entailment reasoning rests on the notion that if formula A entails formula B, then every interpretation satisfying A also satisfies B).
Simple RDF interpretation and entailment ignore the "meaning of any of the names in the graph," as described in RDF semantics [29] . Moreover, the W3C RDF semantics recommendation [29] suggests attaching stronger meaning to URI references to gain maximum value from an RDF graph written "in a particular vocabulary." Treating an ontology as a vocabulary, with clearly defined concepts and relationships that are used to 'type' instance values, enables class membership-based entailment reasoning. Creating an RDF graph by using an ontology as the reference knowledge model leads to a "stronger notion of interpretation and entailment" [29] .
The BioPAX ontology provides a common information model based on RDF/XML syntax for various pathway information sources, including, KEGG, Reactome, and BioCyc. Conversely, the gene Ontology-based data integration, subscribing to the Local As View (LAV) data integration theory [30] , not only uses the formal semantics of the ontology language, but is also a scalable and adaptable integration approach. The LAV approach involves the representation of data from original sources in conformance to a common model or schema such as an ontology. An important aspect of the LAV approach is that it "favors the extensibility of the system" [30] , which is critical here, as other data sources may be added in the future.
Another significant feature of ontology-based data integration approach is the use of inference mechanisms for information gain. An ontology is created using a formal language, the Description Logicbased flavor of OWL (OWL-DL) in the case of BioPAX and EKoM, which allows the definition of inference rules that can be interpreted and processed by reasoning tools. Given two genes that interact with one another, for example, we can define an inference rule to assert a new relationship that exists between their respective proteins products (they either bind together or form components of a larger biological pathway).
Related work
In previous work, we successfully created an RDF representation of the complete Entrez Gene data set [31] These projects are similar to the work described in this paper in that they highlight the use of Semantic
Web technologies such as RDF, OWL and SPARQL to achieve relevant biomedical objectives using data from heterogeneous sources. The work described in this paper is also a natural progression from our previous work [31] and the HCLSIG demonstration [21] . Distinct differences include the use of ontologies as a reference model with associated formal semantics, schema mapping between EKoM and the BioPAX ontology, and rules to reconcile heterogeneous instance bases.
Ontological framework
In this section, we give a brief presentation of the BioPAX ontology and discuss the design decisions we made while creating the Entrez Knowledge Model (EKoM). Subsequently, we describe the mapping we created between the EKoM and the BioPAX ontology.
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BioPAX ontology
The BioPAX ontology was created to model biomolecular pathways [39] . (Figure 1 ) and relationships between them such as 'pathway_components' (between 'pathway' and 'interaction') and 'participants' (between 'entity' and 'interaction'). The BioPAX ontology (level 2) is modeled using the OWL-DL language with DL expressivity of ALCHON (D) and has 40 classes with 33 object and 37 data type properties.
Entrez Knowledge Model
Since no formal information model is available for the representation of gene information in the Entrez family of sources (e.g., from Entrez Gene and HomoloGene), we considered the following approaches to creating such a model. We could either create a new ontology to represent gene information from NCBI sources or extend the BioPAX ontology schema to include the concepts and relationships relevant to gene information sources. We chose not to extend the BioPAX ontology, since it was created specifically to model bio-molecular pathways [39] . Our goal in developing the Entrez Knowledge Model (EKoM) is to create a standalone model specific to NCBI gene information sources, and to integrate it with other models such as the BioPAX ontology.
Gene records from Entrez Gene contain information about the gene product(s), the chromosomal location of the genes, the model organisms in which they are found, and the pathways in which these genes are involved. Each record also contains information such as its creation date and current status. The entities represented in EKoM correspond to records in databases (e.g., Entrez Gene records), which we use as a proxy to the corresponding entities in reality (e.g., genes).
EKoM is modeled using the OWL-DL language with SI DL expressivity (i.e., it uses concept negation, universal and existential quantification, intersection, and disjunction between concepts as well as inverse role for relations). There currently are 45 classes defined in EKoM, through which we have tried to capture essential data available in Entrez Gene (Figure 2 ). There are 11 relationships defined in EKoM as object properties, which link together the classes. These named relationships are either defined in the UMLS Semantic Network [41] or specifically created for EKoM. (The relationships defined in reference ontologies, such as the OBO Relation Ontology [42] , were generally too coarse to be useful here.)
Using the example of gene-gene interaction, we describe the modeling approach used for EKoM. Figure 3 illustrates our approach as applied to a specific gene (CHRNA4). The interaction information from Entrez
Gene records includes the "original" gene (CHRNA4) and its gene product (cholinergic receptor, nicotinic, alpha 4 subunit), the "interactant" gene (CHRNB2) and its gene product (neuronal nicotinic acetylcholine receptor beta 2), the textual description of the interaction ("CHRNA4 (alpha-4) interacts with CHRNB2 (beta-2)"), and a reference in the form of a PubMed identifier. We modeled this information using the concepts 'gene,' 'interaction,' 'gene_product,' 'protein_db_identifier,' and 'reference.'
Schema-level integration of EKoM and BioPAX ontology
With the BioPAX ontology, modeling pathway information, and EKoM, modeling gene information in sources from the Entrez system, we have two information models (or schemas) that need to be integrated.
We found three potentially similar concepts in EKoM and the BioPAX ontology, namely 'pathway,'
'protein,' and 'interaction.' We chose to reuse the concepts 'pathway' and 'protein' in EKoM, as defined in the BioPAX ontology, instead of redefining them in EKoM. In contrast, although the 'interaction' concept is present in both EKoM and BioPAX, we identified that its meaning was different in the two models. provides a formal semantic framework for integrating the data from gene resources and pathway resources at the instance level. Specifically, it is implemented through class membership relations between specific entities (e.g., CHRNB2) in these resources and the corresponding concepts in the information model (e.g. 'gene').
Common ontology schema -heterogeneous instance bases
The availability of pathway information from three large sources (KEGG, Reactome and BioCyc)
conforming to the BioPAX ontology offers a critical advantage in building a semantic pathway knowledge repository. The assumption, regarding the three instance datasets, is that the common ontology schema will enable their automatic and seamless integration [22] . In practice, however, the BioPAX ontology (used as knowledge model for the three resources) seems to be interpreted slightly differently by each data source provider. In fact, the semantics of these class properties varies across resources, resulting in heterogeneous instance bases despite the common ontology schema. More specifically, the instantiation of BioPAX ontology differs in the following aspects:
• In KEGG, the URI for 'pathway' instances is based on a unique alpha-numeric identifier. The value of the 'SHORT-NAME' property is the KEGG identifier of the pathway. The value of the 'NAME' property is the textual description of the pathway. Both values are typed as a 'XML schema string' (http://www.w3.org/2001/XMLSchema#string).
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• In Reactome, the URI for 'pathway' instances is based on the textual description of the pathway.
The values of both 'SHORT-NAME' and 'NAME' properties are textual descriptions of the pathway. The pathway identifier is associated with the 'XREF' property.
• In BioCyc, the URI for 'pathway' instances is based on the BioCyc identifier. The value of the 'NAME' property is the textual description of the pathway. No other property from the 'pathway' concept is used.
As illustrated above, the instantiation of the 'pathway' concept in the three pathway resources under investigation differs in subtle but significant ways. In practice, two major types of issues are identified.
First, 'pathway' instances cannot be compared on the basis of their URIs. In addition, the semantics of the properties of the 'pathway' concept in BioPAX (e.g., 'SHORT-NAME') differs across resources. As a consequence, the instance bases for the three resources are heterogeneous, and 'pathway' instances cannot be easily compared on the basis of the value of these properties.
These heterogeneous instance bases can be potentially reconciled by using related knowledge such as relationships and values associated with each 'pathway' instance. The Pathway Knowledge Base (PKB) [43] discusses the integration of the three BioPAX conformant data sources using Jena [44] to create RDF objects to create a unified store. To support querying across the three data sources, PKB preprocesses the data for syntactic reconciliation including uniformly converting all BioPAX level 1 references to level 2 and use of a standardized namespace (http://pkb.stanford.edu). In our work, we focused on semantic reconciliation that is partially based on syntactic reconciliation (discussed in the next section).
Reconciling heterogeneity among instances
The heterogeneity among pathway instances is not only syntactic (e.g., different format for the identifiers), but also semantic. For example, as described in the previous section, the identifier for a pathway instance in Reactome is the textual description of the pathway, whereas in KEGG it is a unique alpha-numeric value. We used additional knowledge associated with a pathway instance to assess whether two instances are semantically identical or not. This additional knowledge comes from named d r a f t 13 relationships, for example 'bp:SHORT-NAME' and 'bp:XREF,' linking the pathway instance to other entities such as database identifiers and textual descriptions.
For example, as illustrated in Figure 4 , although the instances for calcium signaling pathway are distinct in Entrez Gene and KEGG, we observed that they share the same value (hsa04020) for the 'SHORT-NAME' property. We created a rule to assert the equivalence between the corresponding instances: if two instances from Entrez Gene and KEGG share the same value for the 'SHORT-NAME' property, then they must be considered as one. Technically, we assert an 'owl:sameAs' relation between the two instances, so that a reasoner can interpret them as being semantically identical. Similarly, the 'pathway' instances from Entrez Gene and Reactome that share the same value for the 'XREF' property values are asserted to be identical.
Materials and Architecture
The hypothesis underlying this study is that a mashup of gene and pathway resources created with Semantic Web technologies will help answer complex biological queries related to the genetic basis of nicotine dependence. The primary gene resource to be integrated is Entrez Gene, while Entrez
HomoloGene is used to identify homologous genes in various model organisms. In addition, three pathway information sources-KEGG, Reactome, and BioCyc-are also integrated in the mashup. While the three pathway sources are already available in RDF/XML and conform to the BioPAX ontology schema, the gene resources Entrez Gene and HomoloGene, available in XML, first need to be converted to RDF, conforming to EKoM, the information model we created for these resources. Figure 5 describes the procedure for creating the knowledge base and the overall architecture of the system.
Mapping nicotine dependence genes to Entrez Gene
The list of human genes described in [6] however, multiple records or, more rarely, no records were retrieved from the gene symbol. Ambiguous symbols were disambiguated manually using additional information such as the gene name or chromosomal location. For example, TF mapped to both TF and F3 (for which TF is an alias), and was subsequently disambiguated to TF (GeneID: 7018) using the name "transferrin". When no record was found for the gene symbol, the gene name was used instead of the symbol to query Entrez Gene. For example, the symbol CALCYON did not map to any human genes, but the corresponding name in the original set (D1 Dopamine Receptor-Interacting Protein) mapped to the gene DRD1IP (GeneID: 50632).
At the end of this process, a unique Entrez Gene record was found for each of the 449 genes in the list. 
Identifying homologous genes

Acquiring gene information
Resources from the Entrez family, including Entrez Gene and HomoloGene, are made available by NCBI in XML. However, we use RDF/XML for the representation of our integrated gene-pathway resource.
Therefore, we need to convert XML records from Entrez Gene and HomoloGene to RDF. Moreover, in order to be able to reason over the RDF store, we require the RDF data to conform to the Entrez Knowledge Model (EKoM) we created for this purpose. In other words, entities from the RDF store become instances of the classes and relationships in EKoM schema.
In previous work [31, 46] , we developed a method for converting Entrez Gene records from XML to RDF, based on XPath and XLST stylesheet transformation. The mapping (created manually) between element tags in XML and properties in RDF is recorded as a set of transformation rules in the stylesheet.
This process transforms a relation, implicitly represented in Entrez Gene (e.g., between a given gene and its gene product), into a RDF triple in which this relation is made explicit. Our current works expands this procedure by creating class-membership relations between the instances in RDF and classes from EKoM. 
Acquiring pathway information
The sources of pathway information used in this study include KEGG (Kyoto Encyclopedia for Genes and Genomics) [8] , Reactome [47] and BioCyc [48] . As mentioned earlier, these three resources share a common information model, the BioPAX ontology, and are available in RDF, conforming to either Reactome is a curated knowledgebase of biological pathways resulting from collaboration among Cold Spring Harbor Laboratory, the European Bioinformatics Institute, and the Gene Ontology Consortium.
Reactome contains various types of pathways, including metabolic, signaling, replication and regulation processes. Human pathway information in Reactome is manually curated, whereas non-human pathway information is generated by electronic projection and ortholog mapping. Importantly from an integration perspective, Reactome contains cross-references to other biological resources, including KEGG, UniProt and Entrez Gene. We restricted the extraction of Reactome data to four files corresponding to humans,
C.elegans, mouse and fruit fly. Reactome is available in BioPAX level 2 format.
BioCyc is a collection of pathway/genome databases of predicted and curated metabolic pathways for As noted above, the three resources use different version of the BioPAX format. KEGG and BioCyc use level 1, while Reactome uses level 2. In order to ensure syntactic operability between the three pathway resources, we followed the approach suggested in [43] and converted all BioPAX namespace references in KEGG and BioCyc to the BioPAX level 2 namespace.
Implementation
The Oracle 10g database management system provides native support for RDF and was used as our RDF store. Oracle also provides support for querying RDF triples, rule indices and indexing options for optimization. The total number of RDF triples generated in the knowledge base is about 1.5 million, with the 334,438 triples from Entrez Gene; 695, 301 triples from Reactome; 175, 160 triples from BioCyc and 352, 793 triples from KEGG. The instance files were converted to N3 format (using the Jena API [44] )
prior to being loaded into the Oracle store. The total time taken for this process was about one hour. Three indexes were created, one for each of the three components of an RDF triple: 'subject,' 'object,' and 'predicate.' Using the Oracle implementation of the SPARQL query language [18] , a set of queries was executed against the knowledge base. The average query time was about 30 seconds with the indexes in place.
Queries and results
The integrated resource we created from gene and pathway information can be seen as large graph in which the nodes are instances of the classes in the BioPAX and EKoM ontologies (e.g., genes, proteins, pathways, model organisms) and the edges are semantic relationships among these instances. This graph can be queried with query languages such as SPARQL. In practice, a SPARQL query is the formal d r a f t 18 representation of constraints on the graph. Evaluating the query against the RDF graph consists in the identification of the patterns in the graph that satisfy the query.
This work was motivated by the following three complex biological queries regarding the 449 genes putatively involved with nicotine dependence: Which genes participate in a large number of pathways?
Which genes (or gene products) interact with each other? Which genes are expressed in the brain? In order to answer these questions, we created SPARQL queries, which we executed against the integrated gene-pathway resource in RDF. In this section, we present the rationale for these queries, the approach we used, and the results we obtained.
Which genes participate in a large number of pathways?
Rationale: This query seeks to identify hub genes, that is, those genes involved in a large number of pathways. These genes are most likely to play a particularly important role in biological systems.
Downstream effectors, or proteins in the pathway, are also important as they represent the part of a particular pathway that is "closer" to the phenotypic effect of that pathway. Therefore, the objectives of this query are to 1) confirm the existence in the knowledge base of known hub genes, 2) identify proteins with which those hub genes' products interact or affect, both immediate and downstream, and 3) identify new candidates for further experimental studies.
Approach:
For the 449 genes from the original set and their homologs in four model organisms, the RDF graph is explored to find all pathway entities from the three pathway resources. The list of genes is then ranked by the number of pathways in which the genes are involved.
Results: Table 1 human. When no pathway information is available for a given gene in an organism, it is not possible to distinguish between the absence of study for this pathway in a given organism and a negative finding (i.e., the absence of participation of this particular gene in the pathway).
Using the information returned by this query, we created a gene-pathway network for human genes, involving 247 genes from the original set and 112 pathways ( Figure 6 ). Four of the genes MAPK1, MAPK3, MAP2K1, and CREBBP, involved in many pathways, are found at the center of a cluster of pathways, which provides a graphical rendering of the information in Table 1 . The same view also clearly shows those pathways in which many genes from the original set participate (e.g., SNARE interactions in vesicular transport and Calcium signaling pathway).
Which genes (or gene products) interact with each other?
Rationale: This query also seeks to identify "hub genes", but from the perspective of gene interaction.
These genes might play a particularly important role in nicotine dependence, especially if the genes with which they interact also belong to the original set. This query forms the basis for establishing networks of interacting genes. Results: Five genes from the original set (CALM1, HSP90AA1, GRIN1, SNAP25 and STX1A) interact with more than ten other genes each. Figure 7 shows an interaction network derived from the results of this query for the 449 human genes in the original set. The five top hub genes are highlighted in the network. Table 2 lists the top six interactions with the highest number of mentions. Of note, Table 2 includes mentions of interactions that are not explicitly listed in the gene records from Entrez Gene, but 
Which genes are expressed in the brain?
Rationale: The neurobiology of nicotine dependence has already shown strong connections with various neurotransmitters in the central nervous system. Therefore, we want to identify those genes from the original set that are known to be expressed in various parts of the brain in order, for example, to focus subsequent experimental studies that could then examine gene function.
Approach:
Although specific tissues may be mentioned in textual descriptions in the Entrez Gene record and would be amenable to text mining techniques, no explicit links to tissues can be easily and reliably processed. In contrast, the BioPAX ontology models the anatomical or tissue location using classes such as 'bioSource' and properties such as 'TISSUE,' both linked to 'protein. ' Starting from a gene from Entrez Gene, we can thus follow its links to proteins ('gene' → 'has_product' → 'protein'). As d r a f t 21 mentioned in section 3.3.1, 'protein' is common to EKoM and BioPAX and bridges between gene resources (our starting point) and pathway resources (where we find the information about tissues).
However, although the concept 'protein' is shared by EKoM and BioPAX (at the schema level), protein instances from Entrez Gene and the pathway resources use distinct identification schemes (URIs). As a consequence, it is not possible to automatically exploit tissue information in relation to genes.
Results: Because of heterogeneity in the identification of protein instances, our query did not return any results. However, we verified that if protein instances were reconciled (e.g., through the use of a proteincentric integrative resource such as UniProt), we would be able to link genes to tissues. For example, in 
Discussion and Future Work
Technical significance
The ontology-driven framework for creating integrated knowledge bases outlined in this paper is flexible, sustainable and extensible. Answering complex biological questions typically requires manual work or the development of specific software. In contrast, we showed that the integrated resource we created can be used to answer various types of questions, demonstrating the flexibility of our approach. Because d r a f t 22 manual intervention is required only for the creation of the ontology and linkage between XML element tags and classes and relationships from the ontology, it is possible to process large volumes of data automatically and to update sources frequently. Our effort is therefore likely to be sustainable. Finally, additional information sources (e.g., transcriptome resources such as UniGene and proteome resources such as UniProt), can easily be added to the integrated resource by extending the ontology or integrating with other ontologies to accommodate new types of instances.
Some key issues encountered in this study are worth discussing and include the central role played by the ontology in typing instances, the inference of new knowledge (i.e., information gain) and the reconciliation of heterogeneous instances. But first, we want to emphasize the benefit of using Semantic
Web technologies for data integration.
Semantic Web technologies vs. traditional approaches. This study showcases Semantic Web
technologies, but could have been realized with traditional approaches as well (e.g., using relational databases techniques). In our experience, Semantic Web technologies offer a simpler, adaptable and scalable approach to integrating biological data. In [49] we discussed the three main data integration approaches, namely, data warehousing, navigational integration and mediator-based integration. The data warehousing approach, such as GUS [50] , involves importing and storing data locally in a common format. Navigational integration, exemplified by Entrez [51] , creates cross-references that enables users to navigate across different data sources, interlinking resources without really integrating them. In mediator-based integration, such as in TAMBIS [14] , queries are rewritten by the system before being executed against remote data sources. The approach proposed in this paper is based on Semantic Web technologies, but shares some of the features of the traditional approaches. It requires the various data sources to be converted into a common format, here RDF. The RDF store constitutes a large graph and links among entities are reminiscent of navigational integration. Finally, our approach relies on ontologies to support inference, which is also a feature of many mediator-based systems.
There are, however, several key differences between our approach and traditional data integration methods. The benefit of using Semantic Web technologies for biological data integration can be outlined d r a f t 23 as follows. Unlike databases, Semantic Web technologies provide built-in support for inference (e.g., subsumption reasoning), making it possible to infer new knowledge from existing knowledge sources (discussed later in this section). Ontologies are more expressive than database schemas and can be extended more easily. Moreover, unlike database schemas, ontologies provide a representation of entities and the relations among them that is independent of storage considerations. For these reasons, we believe that an RDF store organized around an ontology provides a simpler model and is easier for a biologist to conceptualize and query.
Although the query time was generally longer with our RDF store than expected with well-tuned relational databases, the advantages of Semantic Web technologies discussed above clearly outweigh the performance issues observed in our study. Moreover, the query time presented here must be understood as the lower bound of performance, because limited resources were spent on optimization in this feasibility study. One solution to this problem would be for the community to create a resolution service for instances, which could take the form of a common registry. This approach would be costly and difficult to maintain d r a f t as the resources to be integrated evolve. Alternatively, reconciliation can be implemented locally and automatically if rules can be created from the information available in the sources. We used the latter approach in this study. As mentioned in section 3.3.2, instances referring to the same entity in different sources were identified automatically by leveraging cross-reference information and linked together using the 'owl:sameAs'property.
Significance for biologists
Today, a major contribution of information technologies to biology remains facilitating the work of biologists by enabling them to integrate information from heterogeneous sources and process large amounts of data. This integration then can facilitate the generation of new hypotheses about biological significance to be confirmed by future experiments.
We showed that it was possible to integrate gene and pathway information into a common framework and to reason over the integrated resources, taking advantage of an ontology to ensure the consistency of and facilitate queries against the knowledge base we created. We also showed that standard tools and technologies could support various types of queries and that the information returned by these queries could be easily converted to produce the kinds of representations used by biologists (e.g., interaction networks created with Cytoscape).
Among the 449 genes from the original set, only 247 are linked to pathways described in the three sources integrated in our knowledge base ( Figure 6 ). Analogously, gene-gene interactions are recorded in our resources for only 219 genes from the original set ( Figure 7 ). In addition to hub genes, likely to play a particularly important role in biological systems, the genes identified by genome-wide linkage and association studies as potentially related to nicotine dependence for which no interactions to other genes and links to pathways are currently recorded probably deserve the attention of researchers.
This study exploits existing knowledge and was not expected to result in any new findings. However, our findings corroborate analyses of some of the same sources (e.g., KEGG) independently conducted by d r a f t 26 other researchers using different techniques [52] . For example, the pathways Neuroactive ligand-receptor interaction and Calcium signaling pathway highlighted in Figure 6 are also mentioned by [52] as being significantly enriched for addiction-related genes. The genes from the MAPK group and the CREBBP gene, which form a cluster of hub genes in Figure 6 are also cited by [52] . Analogously, the five pathways listed by [52] in relation with nicotine dependence (Neuroactive ligand-receptor interaction, Long-term potentiation, GnRH signaling pathway, MAPK signaling pathway and Gap junction) are all present in our dataset and all appear to be linked to at least 15 genes from our original dataset.
Limitations and future work
The study presented here has several limitations, which we plan to address in the future, regarding the heterogeneity of instances, the identification of anatomical information and the absence of integration between structured information sources and the biomedical literature.
Heterogeneity of instances.
As mentioned earlier, the presence in the knowledge base of distinct instances referring to the same entity results in limited integration between information sources. In this study, we observed this phenomenon mostly for proteins and pathways. Proteins were generally identified by their name, making it difficult to match them exactly and reliably across resources. Pathways, on the other hand, were generally identified with identifiers local to a given resource, making it impossible to relate them across sources in the absence of a mapping service. We solved the problem in part for pathways by exploiting the cross-reference information provided in some sources, such as Reactome. We would need to integrate additional information sources to bridge across namespaces for proteins. We plan to integrate UniProt for this purpose.
Anatomical information. The reason why Query 3 (Which genes are expressed in the brain?) was not successful is not because of the absence of anatomical information, but rather because it was extremely difficult to bridge between proteins across resources due to instance heterogeneity. Moreover, extracting anatomical information from the comments field in Reactome, related to the 'protein' concept in pathway d r a f t 27 resources by 'bp:COMMENT' relationship, was possible, but not straightforward, as the field had to be parsed for keywords. However, had proteins been perfectly integrated and anatomical information been present in a specific string, queries would still have been suboptimal, due to the absence of a reference ontology of anatomy. In fact, to a biologist, the query "expressed in the brain" is actually a shortcut for "expressed in the brain or any of its parts." An ontology of anatomy such as the Foundational Model of Anatomy [53] would support the expansion of the query by exploiting subclass and partonomic relations among anatomical entities. More generally, reasoning over specialized information sources such as gene and pathway resources often benefits from reference ontologies for domains such as anatomy, diseases, and drugs.
Integrating knowledge extracted from the biomedical literature and structured knowledge bases.
This work is a pilot contribution to the Biomedical Knowledge Repository under development at the U.S National Library of Medicine (NLM) as part of the Advanced Library Services project [54] . This repository integrates knowledge not only from structured resources (database and knowledge bases), but also from the biomedical literature (e.g., MEDLINE), in order to support applications, including knowledge discovery. This study is limited to the information extracted from five structured information sources. However, we are working on the integration of knowledge extracted from MEDLINE citations.
To select the appropriate corpus from MEDLINE, we plan to use not only a PubMed search on "nicotine dependence," but also the list of PubMed identifiers (PMIDs) cited as evidence by the curators of the pathway information sources. Combining these two sources of information, structured and unstructured, is expected to fill the gaps observed in pathway resources for some organisms.
Conclusion
Semantic Web technologies provide a valid framework for information integration in the life sciences.
We illustrated how two gene information sources (Entrez Gene and HomoloGene) and three pathway information sources (KEGG, Reactome and BioCyc) can be integrated into a knowledge base using RDF d r a f t for its representation. Ontology-driven semantic integration represents a flexible, sustainable and extensible solution to the integration of large volumes of information. Because instance entities are typed with classes from the ontology, ontology-driven integration ensures the consistency of the knowledge base and facilitates the query process. For example, we showed that queries could be formulated for the class 'gene' as a whole, not only for individual gene instances. This work also illustrates the versatility of the integration framework, as no specific tools are required to produce results that can be imported in the tools used by biologists for visualization purposes. The limitations encountered in this study can be compensated for by integrating additional resources to bridge across namespaces (e.g., UniProt), to support reasoning (e.g., anatomical ontologies), and to broaden the scope of information sources (e.g., with information extracted from the biomedical literature).
Legends Table 1 . List of 10 genes participating in the largest number of pathways (ordered by genes in humans) 
